Cheetah Medical

What Cheetah Medical does

Cheetah Medical is a medical device company founded in 2001 and headquartered in Newton Center, Massachusetts, that developed the Starling Fluid Management Monitoring System, a non-invasive hemodynamic monitoring device for hospital settings. The company's core technology is patented Bioreactance, which analyzes changes in electrical signals as blood leaves the left ventricle and passes through the aorta to directly measure flow and volume at the thorax (a "True Volume Event") rather than converting pressure measurements to volume. The Starling system delivers dynamic fluid responsiveness assessments in approximately 48 seconds with 94% sensitivity and 100% specificity, supports both passive leg raise and bolus testing protocols, and provides continuous beat-by-beat monitoring of Cardiac Index, Cardiac Output, Stroke Volume Index, Stroke Volume, and Total Peripheral Resistance. The device is 100% non-invasive, eliminating risks associated with arterial or central lines, and integrates with hospital EMR systems.

Cheetah Medical sells the Starling system primarily to US hospitals and healthcare systems for use in ICU, Emergency Department, Operating Room, Med-Surg, and oncology/infusion clinic settings. The company raised approximately $91M across seven funding rounds from 2010-2018 from investors including Ascension Ventures, Fletcher Spaght, MVM Life Science Partners, Bosch Ventures, HighCape Partners, and Springfield Investments. Its Starling system was acquired by Baxter International Inc. and now operates within Baxter's Infusion Therapies and Technologies division. Cheetah Medical's Bioreactance technology is backed by the FRESH Trial (124 patients across 13 hospital facilities) and a University of Kansas Health System matched study of 100 ICU patients demonstrating 2.89-day reduced ICU length of stay, 51% reduced mechanical ventilation risk, 13.25% reduced acute dialysis initiation, and $14,000+ savings per treated sepsis patient.

Post-acquisition, the Starling system is commercialized through Baxter's direct enterprise sales force, the Baxter US Catalog, and Customer Experience Centers in Irvine CA, Batesville IN, and Raleigh NC. Revenue streams include hardware sales (monitors, sensors, accessories), Baxter Global Service managed service contracts supported by 1,400+ OEM-certified technicians across 140+ service centers, and equipment financing programs (capital leases, operating leases, bridge-to-budget). The Starling Fluid IQ mobile application extends the product into clinician-facing software for fluid management education and case study review. The company holds the registered Starling trademark and SEP-1 Severe Sepsis/Septic Shock Management Bundle inclusion provides regulatory-driven demand in US acute care.

Name

Cheetah Medical

Legal name

Cheetah Medical

Website

https://usstarling.baxter.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

Cheetah Medical develops the Starling Fluid Management Monitoring System, a non-invasive hemodynamic monitoring device using patented Bioreactance technology, now operating as a subsidiary of Baxter International and serving US hospitals across ICU, ED, OR, and Med-Surg care settings.

Ownership category

akta.pro rank

Product category

Non-invasive Hemodynamic Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Non-invasive hemodynamic monitoring
• Cardiac output monitoring
• Fluid responsiveness assessment
• Bioreactance sensing technology
• Medical device hardware

Headquarters

HQ city

Newton Center

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of Starling Fluid Management Monitoring System hardware including portable touch screen monitors, sensors, and accessories for fluid responsiveness monitoring in hospital settings.
2. Service and Support Contracts: Baxter Global Service offers comprehensive service solutions including technical support, preventive maintenance, OEM-certified parts, and remote management services for infusion pumps and monitoring equipment.
3. Financial Services and Equipment Financing: Baxter offers flexible financing solutions including Capital Leases, Operating Leases, and Bridge-to-Budget programs to help healthcare facilities acquire equipment with payment terms meeting cash flow demands.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Cheetah Medical develops non-invasive cardiac output and hemodynamic monitoring hardware, centered on the Starling Fluid Management Monitoring System. The system uses patented Bioreactance technology to assess fluid responsiveness and provide real-time, beat-by-beat measurements of Cardiac Index, Cardiac Output, Stroke Volume Index, Stroke Volume, and Total Peripheral Resistance for hospital clinicians.

Product overview

Cheetah Medical's product offering centers on the Starling Fluid Management Monitoring System, a standalone hemodynamic monitoring device. The system represents the core product in the company's portfolio—a 100% non-invasive fluid management monitoring solution that uses patented Bioreactance technology to provide clinicians with dynamic fluid responsiveness assessments. The product includes a portable touch screen monitor and is supported by the Starling Fluid IQ mobile application available on Google Play.

Differentiator

Problem solved

Functional benefit

Products and services

• Starling Fluid Management Monitoring System

Quantifiable outcome

• 2.89 days reduced ICU length of stay
• +9 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• University of Kansas Health SystemcoreStrategic or Co-development PartnerUniversity of Kansas Health System conducted retrospective matched study of 100 ICU patients with severe sepsis and septic shock using the Starling system for stroke volume guided resuscitation. Study demonstrated positive patient outcomes including reduced ICU length of stay, reduced mechanical ventilation risk, and significant cost savings, providing key clinical evidence for the product.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Edwards Lifesciences: Edwards Lifesciences is the dominant player in ICU and perioperative hemodynamic monitoring with its FloTrac/Vigileo, ClearSight, and traditional pulmonary artery catheter (Swan-Ganz) portfolio. It competes head-to-head with the Starling system across the same clinical use cases of cardiac output and fluid responsiveness measurement.
• LiDCO: LiDCO provides minimally invasive hemodynamic monitoring solutions (LiDCOplus, LiDCOrapid) using lithium dilution calibration for cardiac output and fluid management in critical care. It directly competes with the Starling system for fluid responsiveness monitoring in ICU and surgical patients.
• Deltex Medical: Deltex Medical's CardioQ esophageal Doppler is a non-invasive alternative for cardiac output measurement used in surgical and ICU fluid management. It targets the same healthcare professionals and clinical use cases as the Starling Bioreactance system.
• Uscom: Uscom manufactures the USCOM 1A, a non-invasive ultrasonic cardiac output monitor used in adult, pediatric, and neonatal critical care. It is a direct competitor offering an alternative non-invasive approach to cardiac output and fluid responsiveness measurement.

Emerging players

• Caretaker Medical: Caretaker Medical develops continuous non-invasive blood pressure and hemodynamic monitoring using a finger-cuff sensor and wireless platform. It is an emerging competitor in the non-invasive ICU monitoring space where the Starling system also competes.

Broad incumbents

• GE HealthCare: GE HealthCare integrates hemodynamic parameters into its broad CARESCAPE and IntelliVue patient-monitoring platforms used in hospital critical care. It competes indirectly with the Starling system by bundling hemodynamic measurements within larger multi-parameter monitors installed across US and global hospitals.
• Philips: Philips offers IntelliVue and similar connected patient monitoring solutions that incorporate hemodynamic measurements in the ICU. While broader than Cheetah Medical's dedicated hemodynamic focus, Philips competes for the same hospital budget and clinician attention.
• Masimo: Masimo's rainbow SET platform and connected patient monitoring solutions include hemodynamic and non-invasive measurement capabilities. Masimo further acquired LiDCO, making it a broad incumbent with both non-invasive and minimally invasive hemodynamic offerings.
• Mindray: Mindray provides a broad patient monitoring and medical device portfolio that includes hemodynamic monitoring modules for ICU and perioperative care, competing with the Starling system across global hospital accounts.
• Dräger: Dräger's Infinity and Perseus patient monitoring systems integrate hemodynamic parameters for ICU and anesthesia applications. It addresses overlapping clinical use cases to the Starling system through its broader anesthesia-and-monitoring installed base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Cheetah_Medical
• Facebookfacebook.com/277277189041181
• LinkedInlinkedin.com/company/cheetah-medical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cheetah Medical